Last checked at 
Oxford BioDynamics PLC - biotechnology firm focused on discovery and development of epigenetic biomarkers - Signs supply and resale agreement with NYSE-listed Agilent Technologies, which operates in life sciences, diagnostics and applied chemical markets.
Under its terms, Agilent will supply a custom-made SurePrint G3 CGH Microarray for Oxford BioDynamics' EpiSwitch Explorer Array kit, which is for 3D genome profiling and biomarker discovery.
OBD meanwhile will have exclusive rights for the kit's supply and distribution.
Current stock price: 101.00 pence
Year-to-date change: up 22%
By Dayo Laniyan; dayolaniyan@alliancenews.com
Copyright 2021 Alliance News Limited. All Rights Reserved.
